These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1441362)

  • 1. [The significance of the antioxidant properties of emoxipin in the combined treatment of patients with chronic heart failure].
    Rudyk BI; Sabadyshin RA
    Lik Sprava; 1992 Apr; (4):25-8. PubMed ID: 1441362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Emoxipine correction of lipid peroxidation disorders in patients with osteoarthrosis deformans].
    Shved NI; Belozetskaia-Smiian SI
    Vrach Delo; 1991 Oct; (10):101-3. PubMed ID: 1803728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The antioxidant effects of emoxipin in patients with iron-deficiency anemia].
    Shved MI; Palamar TO
    Lik Sprava; 1995; (9-12):72-5. PubMed ID: 8983799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of emoxipine on lipid peroxidation in patients with chronic heart failure].
    Rudyk BI; Sabadyshin RA
    Kardiologiia; 1991 Nov; 31(11):52-4. PubMed ID: 1805067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The results of using emoxipine in true eczema].
    Grikurov KG; Fedorov SM
    Vestn Dermatol Venerol; 1990; (4):67-9. PubMed ID: 2389614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of emoxipin in treatment of arterial hypertension in the Far North].
    Vershinina AM; Gapon LI; Shurkevich NP; Bazhukhina IF; Petelina TI; Savel'eva NIu
    Klin Med (Mosk); 1999; 77(12):43-6. PubMed ID: 10684216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparative study of the hemodynamic and antioxidant effects of Capoten and prazosin in patients with refractory heart failure].
    Sabadyshyn RO; Rudyk BI; Blinova NH; Slipak OIa
    Lik Sprava; 1997; (2):72-6. PubMed ID: 9333490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The results of research on the antioxidant emoksipin in clinical eye diseases].
    Egorov EA; Shvedova AA; Obraztsova IA
    Vestn Oftalmol; 1989; 105(5):52-5. PubMed ID: 2595902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic significance of local and systemic indicators of lipid peroxidation and antioxidant system in perforating wounds of the eyes and their time course during local antioxidant treatment].
    Arkhipova LT; Dolgova IG
    Vestn Oftalmol; 2001; 117(5):37-40. PubMed ID: 11765467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The efficacy of emoxipin and neoton in unstable stenocardia].
    Golikov AP; Riabinin VA; Golikov PP; Davydov BV; Polumiskov VIu; Rudnev DV; Taranova ZV
    Ter Arkh; 1996; 68(1):31-3. PubMed ID: 8644026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of complex therapy with emoxipin on the course of diabetic retinopathy].
    Kozlov SA; Khyshiktuev BS; Logunov NA
    Vestn Oftalmol; 2003; 119(2):28-30. PubMed ID: 13678005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathogenetic bases of the use alpha-tocopherol and emoxypin in acute hemorrhage].
    Matveev SB; Marchenko VV; Golikov PP
    Vestn Akad Med Nauk SSSR; 1991; (9):38-42. PubMed ID: 1750243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in lipid peroxidation in patients with heart failure combined with symptomatic arterial hypertension].
    Puzik SG
    Lik Sprava; 2000; (3-4):28-31. PubMed ID: 10921254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of emoxipine and histochrome on lipid peroxidation and activity of serum MB-creatine phosphokinase in patients with ischemic heart disease during aortocoronary shunting].
    Lasukova TV; Uskina EV; Afanas'iev SA; Ponomarenko IV; Naryzhnaia NV; Cherniavskiĭ AM; Lishmanov IuB
    Eksp Klin Farmakol; 1997; 60(5):51-3. PubMed ID: 9483407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Emoxipin as an inhibitor of angiogenesis].
    Sologub AA; Akberova SI; Ziangirova GG
    Biull Eksp Biol Med; 1992 Dec; 114(12):620-2. PubMed ID: 1284038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The dynamics of the individual profiles of brain asymmetry in patients with craniocerebral trauma under the influence of emoxipin treatment].
    Fedulov AS; Teterkina TI; Oleshkevich FV
    Zh Vopr Neirokhir Im N N Burdenko; 1992; (4-5):17-9. PubMed ID: 1334306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The action of sodium oxybutyrate and emoxypin on the functional state of the adrenaline-damaged myocardium in an experiment].
    Sysoliatina NA; Artamonova VV
    Eksp Klin Farmakol; 1998; 61(2):30-2. PubMed ID: 9621170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Membranous aspects of kidney transplantation and reasons of transplant antioxidant defense].
    Berdichevskiĭ BA; Tsvettskikh VE; Zhmurov VA; Kononov SL; Berdichevskaia EB; Zhuravleva TD; Kiianiuk NS; Razumiak TV; Nedorezoniuk SV
    Urologiia; 2000; (2):18-20. PubMed ID: 11186720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of trekrezan on the lipid peroxidation in patients with chronic cardiac insufficiency].
    Sabadyshin RO; Slipak OIa; Koval'chuk SF; D'iakov VM; Kazimirovskaia VB
    Biull Eksp Biol Med; 1998 Aug; 126(8):186-8. PubMed ID: 9777233
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lipid peroxidation in patients with chronic heart failure].
    Rudyk BI; Sabadyshin RA; Blinova NG
    Ter Arkh; 1991; 63(12):66-9. PubMed ID: 1803606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.